Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-29T08:54:00.836Z Has data issue: false hasContentIssue false
  • English
  • Français

Comparing the onset of action of antidepressants: Comparison of different criteria applied to the same data set

Published online by Cambridge University Press:  16 April 2020

IA Niklson  and
P-E Reimitz
IA Niklson
Affiliation:
Scientific Development Group, NV Organon, Molenstraat 110, PO Box 20, 5340 BH Oss, The Netherlands
P-E Reimitz
Affiliation:
Scientific Development Group, NV Organon, Molenstraat 110, PO Box 20, 5340 BH Oss, The Netherlands
Get access

Summary

The issue of early onset of action (EOA) of an antidepressant was addressed by several authors. Unfortunately so far there is neither consensus nor convention on the definitions of EOA, or on measures and methods of assessments. There are several quite different approaches to the statistical analysis of the data. Our objective was to compare the results concerning EOA obtained by different statistical techniques applied on a data set which was generated by several independent conclusive double-blind, placebo controlled randomised trials with two antidepressants. The following statistical techniques were used: 1) statistically significant difference for the first time; 2) statistically significant and clinically relevant difference for the first time; 3) pattern analysis; 4) classical survival analysis without ‘sustained response’; 5) survival analysis with sustained response. The advantages and drawbacks of different methods are discussed.

Keywords

onset of actionantidepressantsstatistical techniques
Type
Research Article
Information
European Psychiatry , Volume 13 , Issue 3 , May 1998 , pp. 124 - 127
Copyright
Copyright © Elsevier, Paris 1998

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

De Paula, AJM, Omer, LMODiclofensine (Ro 8-4650), a new psychoactive drug: its efficacy and safety in non-psychotic depression under double-blind placebo-controlled conditions Curr Ther Res 1980; 28: 837–844Google Scholar
Huitfeldt, B, Montgomery, SAComparison between zimeldine and amytriptiline of efficacy and adverse symptoms — a combined analysis of four British clinical trials in depression Acta Psychiatr Scand 1983; 68: 55–69CrossRefGoogle Scholar
Quitkin, RM, Rabkin, JG, Ross, D, Stewart, JWIdentification of true drug response to antidepressants. Use of pattern analysis Arch Gen Psych 1984; 41: 782–786CrossRefGoogle ScholarPubMed
Stassen, HH, Delini-Stula, A, Angst, JTime course of improvement under antidepressant treatment: A survival-analytical approach Eur Neuropsychopharmacol 1993; 3: 127–135CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.